Clinical Trials on HER2 Positive Gastric Cancer in Japan
Total 175 results
-
National Cancer Center, JapanH.U. Group Research Institute G.K.RecruitingHER2-positive Breast CancerJapan
-
National Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerUnited States, Japan
-
City of Hope Medical CenterRecruitingGastric Cancer | Gastric Adenocarcinoma | Gastric Cancer Stage IV | Gastric Neoplasm | Gastric Cancer Metastatic to Lung | Gastric Cancer Stage | Gastric Cancer Metastatic to Liver | Gastric Cancer Stage III | Gastric Cancer Stage II | Gastric Lesion | Gastric Cancer in Situ | Gastric Cancer Stage IIIB | Gastric... and other conditionsUnited States, Japan
-
Japan Breast Cancer Research GroupChugai PharmaceuticalUnknownHER2-positive Locally Advanced or Metastatic Breast CancerJapan
-
Astellas Pharma IncCompletedGastric Cancer | Gastro-esophageal Junction (GEJ) CancerJapan
-
Osaka Medical CollegeCompletedBreast Cancer | Effects of Chemotherapy | HER-2 Positive Breast CancerJapan
-
Osaka Medical CollegeTerminatedBreast Cancer | HER-2 Positive Breast Cancer | Estrogen Receptor Negative NeoplasmJapan
-
Novartis PharmaceuticalsCompletedStomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 ProteinTaiwan, Switzerland, Korea, Republic of, Germany, United States, Japan
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive, HER2-negative, Advanced Breast CancerJapan, Hong Kong, Singapore
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGastric Cancer | Metaplasia | Stage I Gastric Cancer | Initial-onset Gastric CancerJapan
-
Shizuoka Cancer CenterUnknown
-
AstraZenecaTerminatedMetastatic, Gastric or Gastro-oesophageal Junction, CancerKorea, Republic of, Spain, Taiwan, Germany, Japan
-
AmgenCompletedGastric or Gastroesophageal CancerJapan
-
Eisai Co., Ltd.Completed
-
National Cancer Center Hospital EastMerck Sharp & Dohme LLC; Eisai Co., Ltd.CompletedAdvanced Gastric CancerJapan
-
Nihon Pharmaceutical Co., LtdCompletedGastric Cancer | Gastric Adenoma | Colon Nos Polypectomy Tubular AdenomaJapan
-
AstraZenecaRecruitingER-Positive HER2-Negative Breast CancerUnited States, Israel, Spain, Korea, Republic of, Italy, Poland, Belgium, Norway, Bulgaria, France, Germany, United Kingdom, Japan, Taiwan, Canada, Hungary, Australia, Austria, Portugal, Turkey, Russian Federation, Slovakia, Switzer...
-
Hamamatsu UniversityUnknownGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Colon CancerJapan
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer | Breast Neoplasms | HER2-positive Early Breast CancerUnited States, Italy, Spain, Poland, Taiwan, Thailand, Canada, Germany, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, China, Saudi Arabia, Russian Federation, Bulgaria
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingHER2 Positive Breast CancerUnited States, Taiwan, Canada, Korea, Republic of, Austria, China, Spain, Japan, France, Italy, Switzerland, Australia, Belgium, Brazil, Germany, Portugal, United Kingdom, Netherlands, Czechia, Greece, Chile, Finland, Poland
-
Eastern Network of Cancer Immunological Therapy...Terminated
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerJapan
-
M.D. Anderson Cancer CenterRecruitingGastrostomy | GastroEsophageal Cancer | GastricUnited States, Japan, Korea, Democratic People's Republic of
-
Seagen Inc.RecruitingHER2-positive Breast CancerUnited States, Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Singapore, Spain, Sweden, Switzerland, Taiwan, United Kingdom
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer; HER2-positive; MetastaticUnited States, Belgium, Canada, Denmark, Italy, Spain, Hungary, Taiwan, Turkey, France, Germany, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, United Kingdom, China, South Africa, Israel, Russian Federation, Argentina, ... and more
-
AstraZenecaActive, not recruitingER-Positive HER2-Negative Breast CancerAustria, Belgium, France, Germany, Italy, United Kingdom, United States, Canada, India, Taiwan, Russian Federation, Korea, Republic of, Hungary, Japan, Mexico, Turkey, China, Malaysia, Spain, Czechia, Portugal, Poland, Norway, Bulgaria, Slovaki... and more
-
Novartis PharmaceuticalsCompletedAdvanced Gastric CancerJapan
-
Erasme University HospitalTerminatedEarly Gastric Cancer | Rectal PolypJapan, Germany, Belgium
-
German Breast GroupPfizer; AGO Study Group; Breast International Group; NSABP Foundation IncCompletedBreast Cancer | Hormonreceptor Positive | Her2-normal | Postneoadjuvant Treatment With CDK 4/6 Inhibitor | CPS-EG ScoreUnited States, Australia, Austria, Canada, France, Germany, Ireland, Japan, Korea, Republic of, Spain, United Kingdom
-
Daiichi Sankyo, Inc.AstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research...Active, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast CancerUnited States, Spain, France, Germany, Korea, Republic of, United Kingdom, Denmark, Israel, Belgium, Taiwan, Chile, Italy, Japan, Peru, Portugal, China, Turkey, Canada, Ireland, Australia, Greece, Czechia, Singapore, Poland, Romania, Arge... and more
-
National Cancer Center, JapanOno Pharmaceutical Co. Ltd; Fiverings Co., Ltd.CompletedGastric Cancer | Gastroesophageal Junction Region (GEJ) CancerJapan
-
Eisai Co., Ltd.CompletedBreast Cancer | HER2-negative Breast CancerJapan
-
Hamamatsu UniversityYokoyama Foundation for Clinical PharmacologyUnknownGastric Cancer | Gastric Ulcer | Duodenal UlcerJapan
-
PfizerCompletedStomach Neoplasms | Advanced Gastric CancerKorea, Republic of, Japan
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, A... and more
-
Wakayama Medical UniversityCompleted
-
Nihon Pharmaceutical Co., LtdCompleted
-
Tokyo Metropolitan Oncology GroupUnknown
-
Tokyo UniversityCompletedGastric CancerJapan
-
Wakayama Medical UniversityCompleted
-
Genentech, Inc.RecruitingEstrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerKorea, Republic of, United States, Spain, Taiwan, United Kingdom, Japan, Germany, Argentina, Turkey, Greece, Italy, Singapore, South Africa
-
National Cancer Center Hospital EastMerck Sharp & Dohme LLCRecruiting
-
Hokkaido Gastrointestinal Cancer Study GroupSuspendedGastric CancerJapan
-
Chinese University of Hong KongChangi General Hospital; Kosin University Gospel Hospital; Shizuoka Cancer Center and other collaboratorsCompletedEarly Gastric Cancer | Gastric NeoplasmJapan, Singapore, Korea, Republic of, Hong Kong
-
Iwate Medical UniversityUnknown
-
Kinki UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
AstraZenecaDaiichi Sankyo Co., Ltd.Active, not recruitingAdvanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,BreastItaly, Spain, United States, France, Korea, Republic of, Japan, Canada, Denmark, Belgium
-
Hokkaido Gastrointestinal Cancer Study GroupHokkaido University HospitalSuspended
-
Kagawa UniversityCompletedGastric Cancer | ChemoradiationJapan
-
Epidemiological and Clinical Research Information...Unknown